Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2,864,322
-
Total 13F shares
-
2,643
-
Share change
-
+2,643
-
Total reported value
-
$12,395
-
Price per share
-
$4.69
-
Number of holders
-
10
-
Value change
-
+$12,395
-
Number of buys
-
10
Institutional Holders of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) as of Q1 2024
As of 31 Mar 2024,
Aptevo Therapeutics Inc. - Common Stock, $0.001 par value (APVO) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,643 shares.
The largest 10 holders included
Tower Research Capital LLC (TRC), BlackRock Inc., MORGAN STANLEY, Qube Research & Technologies Ltd, OSAIC HOLDINGS, INC., JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, FIFTH THIRD BANCORP, PNC Financial Services Group, Inc., and Truvestments Capital LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.